Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rohit Aggarwal

Showing results (91-100 of 262) with videos related to

Pageof 27
Sort By:
Human Pathology|April 29, 2014
The pulmonary histopathologic manifestations of the anti-PL7/antithreonyl transfer RNA synthetase syndromeSamuel A Yousem, Frank Schneider, David Bi, et al.
Journal of Clinical Neuromuscular Disease|November 20, 2015
Histopathologic Findings in 5 Patients With Hypomyopathic Dermatomyositis: The Importance of MHC-1 Expression on MyofibersAhmed M El-Dokla, Rohit Aggarwal, Chester V Oddis, et al.
Rheumatology (Oxford, England)|November 13, 2016
Cutaneous improvement in refractory adult and juvenile dermatomyositis after treatment with rituximabRohit Aggarwal, Priyadarshini Loganathan, Diane Koontz, et al.
Rheumatology (Oxford, England)|June 22, 2023
Discordance between patient- and physician-reported disease activity in adult idiopathic inflammatory myopathyShiri Keret, Didem Saygin, Siamak Moghadam-Kia, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|January 24, 2022
Prevalent Drug Usage Practices in Adults and Children With Idiopathic Inflammatory Myopathies: Registry-Based Analysis From the MyoCite CohortPankti Mehta, Upendra Rathore, R Naveen, et al.
Journal of the American Academy of Dermatology|June 19, 2026
Cutaneous Vasculopathy in Autoimmune Connective Tissue Diseases - Need for a Standardized Evaluation toolSweta Subhadarshani, Anuradha Bishnoi, Edoardo Conticini, et al.
Medicine|January 12, 2021
Prospective, double-blind, randomized, placebo-controlled phase III study evaluating efficacy and safety of octagam 10% in patients with dermatomyositis ("ProDERM Study")Rohit Aggarwal, Christina Charles-Schoeman, Joachim Schessl, et al.
Clinical Rheumatology|March 16, 2022
Systemic lupus erythematous after Pfizer COVID-19 vaccine: a case reportChantal Lemoine, Cristina Padilla, Noah Krampe, et al.
Dermatology and Therapy|September 12, 2024
Cutaneous Manifestations in Patients with Dermatomyositis, Are They Only Skin Deep?Stephanie McKee, Jason Xenakis, Harriet Makin, et al.
Journal of Clinical Pathology|June 4, 2014
Pulmonary pathologic manifestations of anti-glycyl-tRNA synthetase (anti-EJ)-related inflammatory myopathyFrank Schneider, Samuel A Yousem, David Bi, et al.
Pageof 27

Showing results (91-100 of 262) with videos related to

Sort By:
Pageof 27
Human Pathology|April 29, 2014
The pulmonary histopathologic manifestations of the anti-PL7/antithreonyl transfer RNA synthetase syndromeSamuel A Yousem, Frank Schneider, David Bi, et al.
Journal of Clinical Neuromuscular Disease|November 20, 2015
Histopathologic Findings in 5 Patients With Hypomyopathic Dermatomyositis: The Importance of MHC-1 Expression on MyofibersAhmed M El-Dokla, Rohit Aggarwal, Chester V Oddis, et al.
Rheumatology (Oxford, England)|November 13, 2016
Cutaneous improvement in refractory adult and juvenile dermatomyositis after treatment with rituximabRohit Aggarwal, Priyadarshini Loganathan, Diane Koontz, et al.
Rheumatology (Oxford, England)|June 22, 2023
Discordance between patient- and physician-reported disease activity in adult idiopathic inflammatory myopathyShiri Keret, Didem Saygin, Siamak Moghadam-Kia, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|January 24, 2022
Prevalent Drug Usage Practices in Adults and Children With Idiopathic Inflammatory Myopathies: Registry-Based Analysis From the MyoCite CohortPankti Mehta, Upendra Rathore, R Naveen, et al.
Journal of the American Academy of Dermatology|June 19, 2026
Cutaneous Vasculopathy in Autoimmune Connective Tissue Diseases - Need for a Standardized Evaluation toolSweta Subhadarshani, Anuradha Bishnoi, Edoardo Conticini, et al.
Medicine|January 12, 2021
Prospective, double-blind, randomized, placebo-controlled phase III study evaluating efficacy and safety of octagam 10% in patients with dermatomyositis ("ProDERM Study")Rohit Aggarwal, Christina Charles-Schoeman, Joachim Schessl, et al.
Clinical Rheumatology|March 16, 2022
Systemic lupus erythematous after Pfizer COVID-19 vaccine: a case reportChantal Lemoine, Cristina Padilla, Noah Krampe, et al.
Dermatology and Therapy|September 12, 2024
Cutaneous Manifestations in Patients with Dermatomyositis, Are They Only Skin Deep?Stephanie McKee, Jason Xenakis, Harriet Makin, et al.
Journal of Clinical Pathology|June 4, 2014
Pulmonary pathologic manifestations of anti-glycyl-tRNA synthetase (anti-EJ)-related inflammatory myopathyFrank Schneider, Samuel A Yousem, David Bi, et al.
Pageof 27